<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 23-month-old boy was brought to the emergency department of an adult and pediatric tertiary care center 1 hour after an inadvertent “double dose” of 120 mg flecainide (9.2 mg/kg) </plain></SENT>
<SENT sid="1" pm="."><plain>His electrocardiogram revealed sinus rhythm with a terminal R wave in aVR greater than 7 mm, a bifascicular block, and prolonged QRS and QTc intervals </plain></SENT>
<SENT sid="2" pm="."><plain>A dramatic improvement in the bifascicular block and terminal R wave occurred after the administration of <z:chebi fb="17" ids="32139">sodium bicarbonate</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>He was discharged after 36 hours with no complications </plain></SENT>
<SENT sid="4" pm="."><plain>This case demonstrates that flecainide can cause significant cardiac conduction disturbances in doses much lower than previously described </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> supratherapeutic ingestions should be assessed in hospital </plain></SENT>
</text></document>